Covid19: Clinical Trials

2 trials for Covid19, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Active not recruiting 2

Follow Covid19: new trials by email Literature Review of Covid19 trials Research Report on Covid19

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival
Isoflurane Inhalant Product, Sevoflurane inhalant product - Covid19, Hypoxic Respiratory Failure
Phase 3Active not recruitingSunnybrook Health Sciences Centre8002020-06-152026-02-09
The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients
Cholecalciferol, Placebo - Critical Illness, Vitamin D Deficiency
Phase 3Active not recruitingMedical University of Graz24002017-10-102026-10-09

Narrower conditions

COVID-19 (2)  ·  Critical Illness (1)  ·  Vitamin D Deficiency (1)

Broader conditions

Coronaviridae Infections (2)  ·  Coronavirus Infections (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Nidovirales Infections (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)  ·  Avitaminosis (1)  ·  Deficiency Diseases (1)  ·  Disease Attributes (1)  ·  Malnutrition (1)

Interventions

Cholecalciferol (1)

Sponsors

Medical University of Graz (1)  ·  Sunnybrook Health Sciences Centre (1)

Countries

Austria (1)  ·  Belgium (1)  ·  Canada (1)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Karin Amrein, MD, MSc (1)

Results publications

PMID 31722941, PMID 33757717, PMID 41083292, PMID 42872958